By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Puma Biotechnology 

10940 Wilshire Boulevard
Suite 600
Los Angeles  Caliornia   90024  U.S.A.
Phone: 310-443-4150 Fax: 310-443-4158


SEARCH JOBS








Company News
Puma Biotech (PBYI) Expands Cohort In Phase II SUMMIT Trial Of PB272 In HER2 Mutation-Positive Cancer Patients 1/6/2017 10:36:22 AM
Puma Biotech (PBYI) To Move Stock Exchange Listing To Nasdaq 12/20/2016 1:04:13 PM
Puma Biotech (PBYI) Presents Interim Results Of Phase II Trial Of PB272 For ERBB2 (HER2) Mutant, HER2 Non-Amplified, Metastatic Breast Cancer At The 2016 San Antonio Breast Cancer Symposium 12/8/2016 1:05:16 PM
Puma Biotech (PBYI) Presents Results Of Biomarker Analysis Of Phase II Trial Of PB272 In Neoadjuvant Treatment Of HER2-Positive Locally Advanced Breast Cancer At The 2016 San Antonio Breast Cancer Symposium 12/8/2016 1:03:27 PM
Puma Biotech (PBYI) Presents Interim Results Of Phase II CONTROL Trial Of PB272 In Extended Adjuvant Treatment Of HER2-Positive Early Stage Breast Cancer At The 2016 San Antonio Breast Cancer Symposium 12/8/2016 8:08:23 AM
Puma Biotech (PBYI) Crashes After Diarrhea Risk is Linked to Breast Cancer Drug in Abstract 11/15/2016 5:45:25 AM
Puma Biotech (PBYI) Reports Third Quarter 2016 Financial Results 11/10/2016 3:05:39 PM
Puma Biotech (PBYI) Closes $172 Million Public Offering Of Common Stock 10/25/2016 10:37:12 AM
Puma Biotech (PBYI) Announces Underwriters’ Full Exercise Of Option To Purchase Additional Shares 10/21/2016 8:26:56 AM
Puma Biotech (PBYI)'s $150 Million Stock Offering May Signal to Investors That Its Breast Cancer Drug is in Trouble 10/20/2016 6:50:38 AM
12345678910...
//-->